Alphatec Holdings Inc. (NASDAQ:ATEC) is one of the best high short interest stocks with biggest upside potential. On January 27, TD Cowen lowered its price target for Alphatec to $20 from $27 while maintaining a Buy rating following a transfer of coverage. The firm suggested that the current market expectations do not fully appreciate the company’s growth vectors, such as its recent 2026 revenue outlook of $890 million and the acquisition of exclusive US rights to Theradaptive’s OsteoAdapt bone graft. The firm believes that this undervaluation creates potential for upward revisions to financial estimates as Alphatec continues to execute on its pure-play spine medtech strategy.
Earlier on January 12, Alphatec Holdings Inc. (NASDAQ:ATEC) and Theradaptive entered a landmark partnership granting Alphatec exclusive US commercial rights to market and distribute OsteoAdapt, a breakthrough osteoinductive bone graft for spinal fusion.
Photo by Robb Miller on Unsplash
Announced alongside Theradaptive’s Series B investment round, the agreement is designed to deliver significant long-term value through a structure of upfront and milestone payments coupled with perpetual royalties. This collaboration aims to disrupt the $10 billion US spine biologics market by leveraging Alphatec’s commercial network to provide a protein-engineered regenerative solution that triggers natural bone growth.
Alphatec Holdings Inc. (NASDAQ:ATEC) is a medical technology company that designs, develops, and advances technologies for the surgical treatment of spinal disorders in the US and internationally.
While we acknowledge the potential of ATEC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
